Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
25
HY Quote, Financials, Valuation and Earnings
Last price:
$40.81
Seasonality move
:
-6.5%
Day range:
$39.86 - $41.04
52-week range:
$34.13 - $84.44
Dividend yield:
3.48%
P/E ratio:
7.23x
P/S ratio:
0.17x
P/B ratio:
1.41x
Volume:
45.1K
Avg. volume:
58K
1-year change:
-45.65%
Market cap:
$716.8M
Revenue:
$4.3B
EPS (TTM):
$5.60
Analysts' Opinion
-
Consensus RatingHyster Yale has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $56.00, Hyster Yale has an estimated upside of 38.34% from its current price of $40.48.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $50.00 representing 100% downside risk from its current price of $40.48.
Fair Value
-
According to the consensus of 1 analyst, Hyster Yale has 38.34% upside to fair value with a price target of $56.00 per share.
HY vs. S&P 500
-
Over the past 5 trading days, Hyster Yale has underperformed the S&P 500 by -4.72% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Hyster Yale does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hyster Yale revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Hyster Yale reported revenues of $910.4M.
Earnings Growth
-
Hyster Yale earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Hyster Yale reported earnings per share of $0.48.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
0.17x
EV / EBIT:
5.97x
EV / Revenue:
0.27x
PEG ratio (5yr expected):
0.45x
EV / Free cash flow:
18.74x
Price / Operating cash flow:
11.78x
Enterprise value / EBITDA:
4.79x
Gross Profit (TTM):
$837.5M
Return On Assets:
4.74%
Net Income Margin (TTM):
2.39%
Return On Equity:
20.01%
Return On Invested Capital:
10.29%
Operating Margin:
2.36%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $3.7B | $4.2B | $4.2B | $1.1B | $910.4M | |
| Gross Profit | $507.1M | $846.9M | $837.5M | $235.7M | $177.7M | |
| Operating Income | $21.8M | $249.9M | $205.1M | $83.8M | $21.5M | |
| EBITDA | $71.8M | $303.6M | $238.4M | $97.5M | $35.5M | |
| Diluted EPS | -$1.36 | $8.62 | $5.60 | $2.93 | $0.48 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Total Assets | $1.9B | $2.1B | $2.1B | $2.1B | $2.1B | |
| Current Liabilities | $823.2M | $1.2B | $1.4B | $1.2B | $1.1B | |
| Total Liabilities | $1.3B | $1.7B | $1.8B | $1.7B | $1.5B | |
| Total Equity | $615.8M | $351.5M | $272.3M | $429.3M | $529.4M | |
| Total Debt | $285.4M | $479M | $560.6M | $474.8M | $484M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$9.5M | $164.1M | $111.9M | $22.4M | -$36.4M | |
| Cash From Investing | -$31.1M | -$36.5M | -$50.9M | -$7M | -$10.3M | |
| Cash From Financing | $37.5M | -$128.5M | -$43.7M | -$30.5M | $25.9M | |
| Free Cash Flow | -$31.9M | $124.5M | $61M | $14.9M | -$47M | |
HY
Sector
Market Cap
$716.8M
$611.3M
Price % of 52-Week High
47.94%
81.21%
Dividend Yield
3.48%
0%
Shareholder Yield
4.18%
2.28%
1-Year Price Total Return
-45.65%
-1.12%
Beta (5-Year)
1.489
0.761
Dividend yield:
3.48%
Annualized payout:
$1.38
Payout ratio:
24.65%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$41.78
200-day SMA
Sell
Level
$49.32
Bollinger Bands (100)
Sell
Level
38.09 - 45.73
Chaikin Money Flow
Sell
Level
-8.6K
20-day SMA
Sell
Level
$40.70
Relative Strength Index (RSI14)
Sell
Level
46.28
ADX Line
Sell
Level
14.8
Williams %R
Neutral
Level
-64.3128
50-day SMA
Sell
Level
$40.91
MACD (12, 26)
Buy
Level
11.29
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Sell
Level
-59.5K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.3614)
Sell
CA Score
(Annual)
Level (-0.4146)
Buy
Beneish M-Score
(Annual)
Level (-2.5467)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.1713)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.
Stock Forecast FAQ
In the current month, HY has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The HY average analyst price target in the past 3 months is $56.00.
-
Where Will Hyster Yale Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hyster Yale share price will rise to $56.00 per share over the next 12 months.
-
What Do Analysts Say About Hyster Yale?
Analysts are divided on their view about Hyster Yale share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hyster Yale is a Sell and believe this share price will drop from its current level to $50.00.
-
What Is Hyster Yale's Price Target?
The price target for Hyster Yale over the next 1-year time period is forecast to be $56.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is HY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hyster Yale is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of HY?
You can purchase shares of Hyster Yale via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hyster Yale shares.
-
What Is The Hyster Yale Share Price Today?
Hyster Yale was last trading at $40.81 per share. This represents the most recent stock quote for Hyster Yale. Yesterday, Hyster Yale closed at $40.48 per share.
-
How To Buy Hyster Yale Stock Online?
In order to purchase Hyster Yale stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 3.58% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.66% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.31% over the past day.
